Globally licensed cannabis company ABcann Global Corp.
(TSX.V: ABCN) (OTCQB: ABCCF) this morning announced its entrance into a
definitive agreement to acquire 100% of the issued and outstanding share capital
of Canna Farms Limited, a premium cannabis company in British Columbia. The
acquisition enables the two complementary businesses to leverage their
strengths prior to the opening of the Canadian adult-use market in the fall.
The transaction value of approximately $133 million will be comprised of $22
million in cash and 92.5 million ABcann shares. The shares will be released
from escrow in six month increments over a total of 30 months. Upon completion
of the transaction, Canna Farms’ co-founders, Daniel Laflamme and Raymond
Laflamme, will each own 16.1% of ABcann’s outstanding shares. They will serve
the combined company as President, Canna Farms and Senior Vice President,
Facilities and Engineering, respectively. Daniel Laflamme will also be appointed
to ABcann’s Board of Directors. Closing of the transaction is anticipated in
August 2018, subject to customary closing conditions, including the conditional
approval of the TSXV and applicable regulatory approvals. “This is a
transformational acquisition, and key benefits include increased production
capacity, an expanded product offering, operational efficiencies, and a more
robust platform to accelerate our growth,” ABcann CEO Barry Fishman stated in
the news release. “We will maximize operational and financial synergies, so
that the combined company will be greater than the sum of its parts.”
To view the full press release, visit http://ibn.fm/oyXmF
About ABcann Global Corp.
ABcann is recognized for high-quality, trusted products and
services. It holds production and sales licenses from Health Canada, and its
flagship facility in Napanee, Ontario contains proprietary plant-growing
technology, centered on its specially designed, environmentally-controlled
growing chambers. This approach results in the production of
pharmaceutical-grade cannabis products. ABcann is expanding its production
capacity and pursuing partnership and product development opportunities
domestically, as well as in select international markets, such as Germany,
Australia and Israel. For more information, visit the company’s website
at www.ABcannGlobal.com
About MissionIRNewsBreaks
MissionIRNewsBreaks provide
a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by
our Team of professional journalists that keep a constant eye on the markets,
these posts are designed to inform you on the latest happenings of our clients
and other publicly traded companies on our radar. From earnings, acquisitions
and agreements to conference attendance and clinical study results, our news
breaks keep you up-to-date with the day’s top movers. MissionIR is primarily
focused on strategic communications. We have executed countless communications
programs to address the needs of companies ranging from start-ups to established
industry leaders, gaining valuable experience and the expertise necessary to
determine the most effective strategy for any given situation.
Please see full terms of use and disclaimers on the Mission
Investor Relations website applicable to all content provided by MIR, wherever
published or re-published: http://www.missionir.com/disclaimer.html
